Q2 and H1 FY27: revenue up 39%, PAT up 72%; Rs 45 crore expansion, NCD redemption

Revenue growth above 20%Profit growth above 25%Negative operating cash flowEmphasis of matterRelated-party transactionsResults View source PDF Explain this filing

NEOGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.6%Reaction day

₹2190.00

prior close

₹2130.00

announcement price

After-mkt

timing

Nifty Microcap 250market+1.4%-6.0% vs market

Specialty Chemicals peers, median of 100sector+1.9%-6.5% vs sector

On the reaction day the stock moved 6.0 pts less than Nifty Microcap 250 and 6.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.1

10m

-2.6

15m

-2.4

30m

-3.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.6+1.4-6.0+1.9-6.5

Next day

-0.6+1.7-2.3+1.0-1.6

+2.9+3.9-1.1+2.3+0.5

+11.4+5.1+6.3+2.7+8.6

+16.9pendingpending+2.6+14.3

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 100Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Standalone Q2 FY27 revenue was Rs 288.00 crore versus Rs 206.68 crore a year ago and PAT Rs 21.14 crore versus Rs 9.31 crore. H1 revenue was Rs 540.28 crore and PAT Rs 40.58 crore, versus Rs 391.26 crore and Rs 23.55 crore. H1 operating cash flow was negative Rs 46.11 crore. Auditors highlighted the Rs 171.52 crore insurance claim. The board approved a Rs 45 crore expansion, early redemption of Rs 200 crore NCDs and related party deals.

Likely market impact

Sharp profit growth and expansion support sentiment, but negative cash flow, share dilution from the QIP and higher NCD interest are risks.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹296.0 Cr	₹208.7 Cr	+41.8%
Operating profit	₹8.76 Cr	₹3.17 Cr	+176.3%
Profit after tax	₹8.23 Cr	₹3.37 Cr	+144.2%
EBITDA margin	15.3%	14.4%	+1.0 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.